Clinical Trial Update: D-amino Acid Oxidase Inhibition (DAAOI-1) add-on Treatment for Chronic Schizophrenia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating D-amino Acid Oxidase Inhibition (DAAOI-1) as an add-on treatment for chronic schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• DAAOI-1

Snippet

Sponsor: China Medical University Hospital | Conditions: Schizophrenias, Psychoses | Phase 2 | Status: COMPLETED